Respiratory Morbidity in Prematurely Born Children Receiving Palivizumab Prophylaxis of Respiratory Syncytial Virus Disease

• Κύριοι συγγραφείς: Milena Bjelica (Συγγραφέας), Gordana Vilotijević Dautović (Συγγραφέας), Slobodan Spasojević (Συγγραφέας), Marija Đermanović (Συγγραφέας), Milica Plazačić (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Mashhad University of Medical Sciences, 2024-04-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Background: Preterm delivery is a risk factor for increased respiratory morbidity in early childhood. This study aimed to quantify respiratory morbidity in preterm survivors, comparing incidence rates among different gestational ages, birth weighst, and current age groups. Additionally, we sought to...